Rideout HJ, Dietrich P, Wang Q, Dauer WT, Stefanis L.
alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons.
J Biol Chem. 2004 Nov 5;279(45):46915-20. Epub 2004 Aug 18.
PubMed
PDF
Stefanis L, Wang Q, Oo T, Lang-Rollin I, Burke RE, Dauer WT.
Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.
Eur J Neurosci. 2004 Oct;20(7):1969-72.
PubMed
PDF
Kholodilov N, Yarygina O, Oo TF, Zhang H, Sulzer D, Dauer W, Burke RE.
Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets.
J Neurosci. 2004 Mar 24;24(12):3136-46.
PubMed
PDF
Rideout HJ, Dietrich P, Savalle M, Dauer WT, Stefanis L.
Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons.
J Neurochem. 2003 Feb;84(4):803-13.
PubMed
PDF
Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, Staal R, Tieu K, Schmitz Y, Yuan CA, Rocha M, Jackson-Lewis V, Hersch S, Sulzer D, Przedborski S, Burke R, Hen R.
Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14524-9. Epub 2002 Oct 10.
PubMed
PDF
Back to Top
|
